Date Filed | Type | Description |
01/19/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/19/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/19/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/28/2020 |
4
| Tenzing LLC (10% Owner) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Disposed of 540,500 warrants
@ $0 |
|
12/28/2020 |
4
| Tenzing LLC (10% Owner) has filed a Form 4 on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Txns:
| Granted 197,500 shares
@ $0 Acquired 343,000 warrants
@ $0 Granted 197,500 warrants
@ $0 |
|
09/04/2018 |
SC 13D
| Tenzing LLC reports a 23.3% stake in Tenzing Acquisition Corp. |
09/04/2018 |
4
| Tenzing LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Bought 33,000 shares
@ $10, valued at
$330k
|
|
08/24/2018 |
4
| Tenzing LLC (10% Owner) has filed a Form 4 on Tenzing Acquisition Corp.
Txns:
| Bought 310,000 shares
@ $10, valued at
$3.1M
|
|
08/20/2018 |
3
| Tenzing LLC (10% Owner) has filed a Form 3 on Tenzing Acquisition Corp. |